63.91
-0.81
(-1.25%)
At close: January 29 at 4:00:02 PM EST
63.90
-0.01
(-0.02%)
Pre-Market: 8:39:16 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 11 | 18 | 16 |
| Avg. Estimate | 0.49 | 2.23 | 6.84 | 7.32 |
| Low Estimate | 0.43 | 1.72 | 6.75 | 7.25 |
| High Estimate | 0.58 | 2.49 | 7 | 8 |
| Year Ago EPS | 0.45 | 2.26 | 6.68 | 6.84 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 8 | 14 | 14 |
| Avg. Estimate | 39.32B | 41.64B | 161.24B | 168.4B |
| Low Estimate | 38.01B | 37.77B | 158.28B | 162.24B |
| High Estimate | 42.02B | 43.5B | 163.28B | 177.19B |
| Year Ago Sales | 39.46B | 40.41B | 154B | 161.24B |
| Sales Growth (year/est) | -0.35% | 3.06% | 4.70% | 4.44% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.44 | 2.08 | 2.09 | 1.41 |
| EPS Actual | 0.45 | 2.26 | 2.42 | 1.62 |
| Difference | 0.01 | 0.18 | 0.33 | 0.21 |
| Surprise % | 2.13% | 8.65% | 16.05% | 14.87% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.49 | 2.23 | 6.84 | 7.32 |
| 7 Days Ago | 0.51 | 2.22 | 6.83 | 7.32 |
| 30 Days Ago | 0.51 | 2.22 | 6.83 | 7.32 |
| 60 Days Ago | 0.5 | 2.33 | 6.83 | 7.12 |
| 90 Days Ago | 0.56 | 2.43 | 6.83 | 7.18 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 6 | 1 | -- |
| Up Last 30 Days | 2 | 5 | 2 | 9 |
| Down Last 7 Days | 2 | 4 | 2 | -- |
| Down Last 30 Days | 2 | 6 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CNC | 9.62% | -1.25% | 2.35% | 7.12% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 12/13/2024 |
| Maintains | Truist Securities: Buy to Buy | 12/13/2024 |
| Maintains | Barclays: Overweight to Overweight | 12/13/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/13/2024 |
| Upgrade | UBS: Neutral to Buy | 12/13/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 12/11/2024 |
Related Tickers
MOH Molina Healthcare, Inc.
304.28
-1.02%
HUM Humana Inc.
294.23
-2.93%
CI The Cigna Group
303.31
+0.16%
ELV Elevance Health, Inc.
400.30
-1.26%
CVS CVS Health Corporation
56.90
-0.75%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
OSCR Oscar Health, Inc.
16.68
+2.46%
NEUE NeueHealth, Inc.
7.34
-0.14%
CLOV Clover Health Investments, Corp.
4.4500
-3.05%